Skip to search formSkip to main contentSkip to account menu

1 ML ixekizumab 80 MG/ML Prefilled Syringe

Known as: IXEKIZUMAB 80MG/ML INJ,SYR,1ML [VA Product], ixekizumab 80 MG per 1 ML Prefilled Syringe, IXEKIZUMAB 80MG/ML INJ 1ML SYR 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

1 ML ixekizumab 80 MG/ML Prefilled Syringe [Taltz]

Broader (1)

Immunosuppressive Agents
Prefilled Syringeixekizumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
FRI0398 IXEKIZUMAB IS EFFECTIVE IN THE TREATMENT OF RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS REGARDLESS OF THE LEVEL OF C-REACTIVE PROTEIN OR MAGNETIC RESONANCE IMAGING SCORES: 16-WEEK DATA FROM COAST-V…
Background Radiographic axial spondyloarthritis (r-axSpA) is a chronic inflammatory disease of the axial skeleton, and… 
2019
2019
FRI0426 IXEKIZUMAB MAKES REMISSION AND LOW DISEASE ACTIVITY POSSIBLE IN PATIENTS WITH PSORIATIC ARTHRITIS: TWO-YEAR RESULTS IN TNF INADEQUATE RESPONDERS OR BIOLOGIC-NAïVE PATIENTS
Background Psoriatic arthritis (PsA) is a heterogeneous inflammatory disease that can involve peripheral and axial joints, skin… 
2017
2017
Psoriasis: Ixekizumab reduziert Juckreiz
Für viele Patienten mit einer Psoriasis ist der Juckreiz das schlimmste Symptom. Beim Plaque-Typ sind 60% betroffen mit negativen… 
2016
2016
Psoriasis: Gutes Ansprechen auf Therapie mit Interleukin-17-Antikörpern
Psoriasis ist eine chronisch-entzündliche Erkrankung der Haut, die durch eine inadäquate Immunantwort und überschießende… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)